Redox status is the mainstay of sars-cov-2 and host for producing therapeutic opportunities

HIGHLIGHTS

  • who: Anand Thirupathi and collaborators from the Faculty of Sports Science, Ningbo University, Ningbo, China have published the paper: Redox Status Is the Mainstay of SARS-CoV-2 and Host for Producing Therapeutic Opportunities, in the Journal: Antioxidants 2022, 11, 2061. of /2022/
  • what: This review discussed several ROS sources that are perhaps activated by SARS-CoV-2 for its survival.
  • how: This review discusses the redox-based perspectives of the entire system during COVID-19 infection including how redox-based molecules impact the accessibility of SARS-CoV-2 to the host and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?